Margarita SharovaAtlas Oncodiagnostics, LLC, Moscow, Russia; Research and Counselling Department, Research Centre for Medical Genetics, Moscow, Russia;
Ekaterina IgnatovaAtlas Oncodiagnostics, LLC, Moscow, Russia; Department of Chemotherapy No. 2, Federal State Budgetary Institution N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia; and Department of Oncogenetics, Institute of Higher and Additional Professional Education, Research Centre for Medical Genetics, Moscow, Russia
DalyMB, PalT, BerryMP, et al.NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021. Accessed August 27, 2021. To view the most recent version, visit NCCN.org
DalyMB, PalT, BerryMP, NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021. Accessed August 27, 2021. To view the most recent version, visit NCCN.org33406487)| false
RichardsS, AzizN, BaleS, et al.ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med2015;17:405–424.
RichardsS, AzizN, BaleS, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405–424.10.1038/gim.2015.3025741868)| false
NykampK, AndersonM, PowersM, Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 2017;19:1105–1117.2849253210.1038/gim.2017.37)| false
HanFF, GuoCL, LiuLH. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis. DNA Cell Biol 2013;32:329–335.2371394710.1089/dna.2013.1970)| false
ThompsonER, GorringeKL, RowleySM, et al.Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context. Sci Rep2015;5:14800.
ThompsonER, GorringeKL, RowleySM, Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context. Sci Rep 2015;5:14800.10.1038/srep14800)| false
MeeksHD, SongH, MichailidouK, et al.BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers. J Natl Cancer Inst2015;108:djv315.
MeeksHD, SongH, MichailidouK, BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers. J Natl Cancer Inst 2015;108:djv315.10.1093/jnci/djv31526586665)| false
ShimelisH, MesmanRLS, Von NicolaiC, BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res 2017;77:2789–2799.10.1158/0008-5472.CAN-16-256828283652)| false
HanMR, ZhengW, CaiQ, et al.Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis2017;38:511–518.
HanMR, ZhengW, CaiQ, Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis 2017;38:511–518.10.1093/carcin/bgx01028419251)| false
HuC, HartSN, GnanaolivuR, A population-based study of genes previously implicated in breast cancer. N Engl J Med 2021;384:440–451.3347197410.1056/NEJMoa2005936)| false
YangY, ShuX, ShuXO, et al.Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. EBioMedicine2019;48:203–211.
YangY, ShuX, ShuXO, Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. EBioMedicine 2019;48:203–211.10.1016/j.ebiom.2019.09.00631629678)| false
SoutheyMC, GoldgarDE, WinqvistR, PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 2016;53:800–811.10.1136/jmedgenet-2016-10383927595995)| false